Insider Transactions Reported by 16 Insiders of Telomir Pharmaceuticals, Inc.

Symbol
TELO on Nasdaq
Location
Miami, FL

There are no Buy or Sell transactions made by insiders since 04 Feb 2025

Telomir Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bay Shore Trust 10%+ Owner $20,414,715 21 Nov 2024
Christopher C. Chapman JR CEO & Chairman, Director $6,048,782 08 Feb 2024
MIRA PHARMACEUTICALS, INC. 10%+ Owner $4,823,943 29 Sep 2025
CRAIG EAGLE Director $3,024,391 08 Feb 2024
Nathen Fuentes Chief Financial Officer $627,031 08 Feb 2024
Bradley Kroenig Director $302,442 08 Feb 2024
Hugh McColl III Director $302,442 08 Feb 2024
Talhia Tuck Director $302,442 08 Feb 2024
Erez Aminov CEO and Chairman, Director $183,520 28 May 2025
Michelle Yanez Chief Financial Officer $151,224 27 Aug 2024
Alan Weichselbaum Chief Financial Officer 15 May 2025
Christos Nicholoudis General Counsel, Director 08 Feb 2024
Jerman A Michael Director 27 Aug 2024
Matthew Pratt Whalen Director 27 Aug 2024
Edward MacPherson Director 27 Aug 2024
Matthew Paul Del Giudice Director 27 Aug 2024

Recent Insider Transactions by Companies or Individuals for Telomir Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.